FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Drug Study Reassures on Product Quality

A new FDA study of 252 difficult-to-make prescription drugs finds that U.S.-marketed products consistently meet quality standards even when manufactur...

Human Drugs

New Drug Manufacturing Data Reporting Delayed: FDA

FDA says it is delaying collection of new drug manufacturing data to help it track potential drug shortages until an electronic data submission portal...

Federal Register

Genentech Wins FDA Priority Review Voucher

FDA issues a priority review voucher to Genentech for gaining approval of a rare pediatric disease product application Evrysdi (risdiplam).

Federal Register

Rule Removes Vaccine Mycoplasma Testing

Federal Register notice: FDA issues a final rule to remove the specified test for detecting the presence of Mycoplasma for live virus vaccines and ina...

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

Federal Register

Regulatory Review Period for Oxervate

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Dompe Farmaceuticis Oxervate (cenegermin-bkbj)....

Federal Register

Public Meeting on CDER Standard Core Sets

Federal Register notice: FDA announces an 8/28 virtual public meeting entitled Public Meeting on CDER Standard Core Sets: Clinical Outcome Assessments...

Medical Devices

Pelvital Flyte Urinary Incontinence Therapy Cleared

FDA cleared a Pelvital 510(k) for Flyte, an intravaginal home-use device that is intended to strengthen the pelvic floor muscles to help women with st...

Medical Devices

Alert on Passive Protective Barrier Enclosures

FDA alerts health care providers that the use of passive protective barrier enclosures when treating Covid-19 patients may pose an increased health ri...

Human Drugs

FDA Warns CBD Web Site Over Covid-19 Claims

FDA cites Living Senior, Las Vegas, NV, over its www.blueribbonhemp.com Web site that markets CBD products for treating Covid-19 patients.